Literature DB >> 23494111

[Fever and lymphadenopathy. Report of 4 cases of tularemia].

C Bloch1, A Friedl, F Zucol, A Widmer, N Khanna.   

Abstract

We report on 4 patients with different types of tularemia acquired in Switzerland or nearby countries. All patients presented with fever, moderate to highly elevated signs of inflammation, and local lymphadenopathy. Additionally, 3 patients did not respond to empirical antimicrobial therapy with aminopenicillins. A tick bite was identified as mode of transmission in 2 patients, while 1 patient showed a possible connection to a tick bite. The route of transmission for the fourth patient remained unknown. The diagnosis of tularemia was either based on positive serology, on a positive polymerase chain reaction (PCR) from the lymph node samples or on positive blood cultures. The treatment in adult patients was ciprofloxacin 500-750 mg twice daily orally for 3 weeks. The pediatric patient was treated with gentamicin 4 mg/kg i.v. once daily for 1 week and ciprofloxacin 15 mg/kg twice daily orally for another 2 weeks. All patients recovered completely. Due to the increasing incidence of tularemia in Switzerland, this infection should be considered in patients with fever and lymph node enlargement particularly after tick bite. We recommend treatment with ciprofloxacin orally for 14-12 days.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494111     DOI: 10.1007/s00108-013-3254-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  10 in total

1.  Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years.

Authors:  Henrik Eliasson; Erik Bäck
Journal:  Scand J Infect Dis       Date:  2007

2.  An outbreak of primary pneumonic tularemia on Martha's Vineyard.

Authors:  K A Feldman; R E Enscore; S L Lathrop; B T Matyas; M McGuill; M E Schriefer; D Stiles-Enos; D T Dennis; L R Petersen; E B Hayes
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

3.  In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.

Authors:  Sandra K Urich; Jeannine M Petersen
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

4.  Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia.

Authors:  A Johansson; L Berglund; U Eriksson; I Göransson; R Wollin; M Forsman; A Tärnvik; A Sjöstedt
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Tularemia epidemic in northwestern Spain: clinical description and therapeutic response.

Authors:  J L Pérez-Castrillón; P Bachiller-Luque; M Martín-Luquero; F J Mena-Martín; V Herreros
Journal:  Clin Infect Dis       Date:  2001-07-06       Impact factor: 9.079

6.  Landmark article April 25, 1925: Tularemia. By Edward Francis.

Authors:  E Francis
Journal:  JAMA       Date:  1983-12-16       Impact factor: 56.272

7.  Public health assessment of potential biological terrorism agents.

Authors:  Lisa D Rotz; Ali S Khan; Scott R Lillibridge; Stephen M Ostroff; James M Hughes
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases.

Authors:  Ingrid B Weber; George Turabelidze; Sarah Patrick; Kevin S Griffith; Kiersten J Kugeler; Paul S Mead
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

Review 9.  Streptomycin and alternative agents for the treatment of tularemia: review of the literature.

Authors:  G Enderlin; L Morales; R F Jacobs; J T Cross
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

10.  The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden.

Authors:  Henrik Eliasson; Johan Lindbäck; J Pekka Nuorti; Malin Arneborn; Johan Giesecke; Anders Tegnell
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

  10 in total
  2 in total

1.  Pediatric Tularemia-A Case Series From a Single Center in Switzerland.

Authors:  Nina Schöbi; Philipp K A Agyeman; Andrea Duppenthaler; Andreas Bartenstein; Peter M Keller; Franziska Suter-Riniker; Kristina M Schmidt; Matthias V Kopp; Christoph Aebi
Journal:  Open Forum Infect Dis       Date:  2022-06-11       Impact factor: 4.423

2.  Long-Lasting Fever and Lymphadenitis: Think about F. tularensis.

Authors:  Maria Vittoria Longo; Katia Jaton; Paola Pilo; David Chabanel; Véronique Erard
Journal:  Case Rep Med       Date:  2015-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.